SATI

Reports estimate that up to 8 million people in the UK use CBD for its variety of wellness benefits. The market is currently worth £300 million, a figure which is

Sativa Group Plc [AQSE: SATI], the UK’s leading quoted CBD wellness and medicinal cannabis company, is launching a new Goodbody Wellness CBD and Vitamin D product range. The brand positioning

There may be over 34 million adult smokers in the US, but nearly 70% of those people are trying to kick the habit. Unfortunately, only a handful are ever successful,

While more countries around the world continue to acknowledge the potential of CBD, the full biological effects of the cannabinoid are yet to be fully understood. However, some research demonstrates

Sativa Group Plc [AQSE: SATI], the UK’s leading quoted CBD wellness and medicinal cannabis company, has recorded a record month of revenues for the Group in June. Record sales have

A new white paper has been published by leaders in the cannabis field, showcasing how to maximise clinical research and improve patient access to medical cannabis in the UK. Following

Hemp and CBD oil were federally legalized with the 2018 Farm Bill, but scientists have been researching cannabidiol and its potential benefits for many years prior to the cannabis boom.

Sativa Group Plc [AQSE:SATI], the UK’s leading quoted CBD wellness and medicinal cannabis Group, has confirmed it is working on its Novel Food application in partnership with Stillcanna Inc, and is

Cannabidiol – the cannabis derivative known more commonly by its abbreviated name, ‘CBD – has gained popularity among people from all walks of life. The cannabinoid has been adopted by

A lot of health claims now surround CBD, some of them more substantiated than others. You may have heard that CBD is an effective anxiety medication, but how true is